Topical and oral voriconazole in the treatment of fungal keratitis

被引:89
作者
Bunya, Vatinee Y. [1 ]
Hammersmith, Kristin M. [1 ]
Rapuano, Christopher J. [1 ]
Ayres, Brandon D. [1 ]
Cohen, Elisabeth J. [1 ]
机构
[1] Wills Eye Hosp & Res Inst, Cornea Serv, Philadelphia, PA 19107 USA
关键词
D O I
10.1016/j.ajo.2006.07.033
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE: To describe nine patients with fungal keratitis refractory to standard antifungal therapy whose condition was managed with voriconazole. DESIGN: Retrospective case series. METHODS: Chart review of patients with fungal keratitis who were treated with topical and oral voriconazole. RESULTS: Nine patients were treated. Two patients were contact lens wearers who used multipurpose cleaning solutions. Corneal isolates found were Fusarium (three patients), Candida albicans (three patients), Alternaria (one patient), Scopulariopsis (one patient), and Scedosporium apicispermum (one patient). Nine patients were treated with topical voriconazole, and eight patients were treated with oral voriconazole. Patients were treated topically for four to 16 weeks (mean, 10 weeks) and orally for five to 17 weeks (mean, 10 weeks). One patient was lost to follow-up. Two patients discontinued the topical voriconazole after one day and four weeks, respectively, because of ocular burning. Of the seven patients who were treated with topical therapy and followed, five conditions healed. CONCLUSION: Voriconazole is a new, promising therapy for fungal keratitis that is refractory to standard antifungal treatments.
引用
收藏
页码:151 / 153
页数:3
相关论文
共 7 条
[1]   Fungal keratitis caused by Paecilomyces lilacinus associated with a retained intracorneal hair [J].
Anderson, KL ;
Mitra, S ;
Salouti, R ;
Pham, TA ;
Taylor, HR .
CORNEA, 2004, 23 (05) :516-521
[2]   Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans [J].
Hariprasad, SM ;
Mieler, WF ;
Holz, ER ;
Gao, H ;
Kim, JE ;
Chi, JD ;
Prince, RA .
ARCHIVES OF OPHTHALMOLOGY, 2004, 122 (01) :42-47
[3]   In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens [J].
Marangon, FB ;
Miller, D ;
Giaconi, JA ;
Alfonso, EC .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2004, 137 (05) :820-825
[4]   Keratitis caused by Scedosporium apiospermum successfully treated with a cornea transplant and voriconazole [J].
Nulens, E ;
Eggink, C ;
Rijs, AJMM ;
Wesseling, P ;
Verweij, PE .
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (05) :2261-2264
[5]   Voriconazole in the management of Alternaria keratitis [J].
Ozbek, Z ;
Kang, S ;
Sivalingam, J ;
Rapuano, CJ ;
Cohen, EJ ;
Hammersmith, KM .
CORNEA, 2006, 25 (02) :242-244
[6]   Effect of voriconazole on a corneal abscess caused by fusarium [J].
Polizzi, A ;
Siniscalchi, C ;
Mastromarino, A ;
Saccà, SC .
ACTA OPHTHALMOLOGICA SCANDINAVICA, 2004, 82 (06) :762-764
[7]   Activity of voriconazole against corneal isolates of Scedosporium apiospermum [J].
Shah, KB ;
Wu, TG ;
Wilhelmus, KR ;
Jones, DB .
CORNEA, 2003, 22 (01) :33-36